Univercells Technologies by Donaldson is a global provider of innovative biomanufacturing technologies, specializing in the development and production of advanced bioreactors. These cutting-edge bioreactors are designed to achieve cost-effective viral production from R&D to commercial scales. The company addresses the growing demand for viral vectors and viral vaccines. Univercells Technologies by Donaldson is committed to help customers increase performance with minimized footprint and costs.